Skip to main content
Clinical Trials/NCT06987110
NCT06987110CompletedNot Applicable

A Randomized Clinical Trial Comparing Transverse Thoracic Plane Block, Midpoint Transverse Process Plane to Pleura Block and Erector Spinae Plane Block for Analgesia in Patients Undergoing Thoracoscopic Sympathectomy

Tanta University1 site in 1 country60 target enrollmentStarted: May 24, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
60
Locations
1
Primary Endpoint
Time to the 1st rescue analgesia

Study Overview

Brief Summary

This study compares the transversus thoracic muscle plane block (TTPB), midtransverse to pleura block (MTPB), and erector spinae plane block (ESPB) for postoperative analgesia in patients undergoing thoracoscopic sympathectomy.

Detailed Description

Thoracoscopic sympathectomy is a well-established procedure for the treatment of various hyperhidrosis disorders and certain vascular conditions, involving the division of sympathetic nerve fibers in the thoracic cavity.

The erector spinae plane block (ESPB) is an interfascial regional anesthesia block for thoracic analgesia which can be performed by superficial or deep needle approach.

The mid-transverse to pleura block (MTPB) was first described as a modified paravertebral block.

Transversus thoracic muscle plane block (TTPB) is a newly developed technique in which LA is injected into the fascial plane between the transversus thoracic muscle and the internal intercostal muscles for blocking the anterior cutaneous branches of intercostal nerves from thoracic (Th) 2 to Th 6.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age from 18 to 65 years.
  • •Both sexes.
  • •American Society of Anesthesiology (ASA) physical status I-II.
  • •Scheduled for thoracoscopic sympathectomy

Exclusion Criteria

  • •Coagulopathy.
  • •History of opiate abuse.
  • •Pre-existing chronic pain.
  • •Allergy to local anesthetics or analgesics.
  • •Infection at the site of injection.
  • •Mental or neurological disorders.
  • •Pregnancy

Arms & Interventions

Transverse thoracic plane block group

Experimental

Patients will receive a transverse thoracic plane block.

Intervention: Transverse thoracic plane block (Other)

Midpoint transverse process plane to pleura block group

Experimental

Patients will receive a midpoint transverse process plane to pleura block.

Intervention: Midpoint transverse process plane to pleura block (Other)

Erector spinae plane block group

Experimental

Patients will receive an erector spinae plane block.

Intervention: Erector spinae plane block (Other)

Outcomes

Primary Outcomes

Time to the 1st rescue analgesia

Time Frame: 24 hours postoperatively

Time to the first request for the rescue analgesia (time from end of surgery to first dose of morphine administrated)

Secondary Outcomes

  • Degree of patient satisfaction(24 hours postoperatively)
  • Total morphine consumption(24 hours postoperatively)
  • Degree of pain(24 hours postoperatively)
  • Heart rate(Till the end of surgery (Up to 2 hours))
  • Mean arterial pressure(Till the end of surgery (Up to 2 hours))
  • Incidence of complications(24 hours postoperatively)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mahmoud Abdalsattar Elmohasseb

Lecturer of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.

Tanta University

Study Sites (1)

Loading locations...

Similar Trials